Last verified: 17 days ago
Eucalyptus
Also known as: Eucalyptus globulus, Eucalyptus oil, 1,8-cineole, eucalyptol, blue gum
Evidence under review. — Not yet rated
Plant-derived oil with early evidence for nasal relief, headache, and antimicrobial uses. Most research is preliminary.
-
What it does
Eucalyptus is a tree whose leaves and oil are used in traditional and modern medicine. The provided studies suggest eucalyptus oil applied inside the nose may reduce dryness, crusting, and...
-
Evidence quality
Evidence base hasn't been formally rated yet. See research below.
-
Clinical dose
No established dose
What the Science Says
Eucalyptus is a tree whose leaves and oil are used in traditional and modern medicine. The provided studies suggest eucalyptus oil applied inside the nose may reduce dryness, crusting, and congestion in elderly patients with rhinitis, and that inhaling eucalyptus aroma may help reduce headache severity in dialysis patients. Lab studies show the leaf extract and its key compound 1,8-cineole have antibacterial and potential anticancer properties, but these findings have not yet been confirmed in human clinical trials.
What It Doesn't Do
Not proven to treat or prevent cancer in humans — lab results don't translate to a cure. Won't reliably improve your sense of smell if it's already normal. No solid evidence it works as a standalone pain reliever — the topical pain study used a multi-ingredient blend, not eucalyptus alone. Don't expect it to kill infections inside your body just because it works in a lab dish.
Evidence-Based Benefits
Topical eucalyptus oil reduced nasal dryness, crusting, and congestion in elderly patients with rhinitis.
Weak EvidenceEffective at: Topical intranasal application for 2 weeks
Supporting studies (click to view on PubMed):
Inhaling eucalyptus aroma reduced headache severity in patients undergoing hemodialysis.
Weak EvidenceEffective at: Inhalation aromatherapy during dialysis sessions
Supporting studies (click to view on PubMed):
Eucalyptus leaf extract inhibits growth of Gram-positive bacteria including MRSA in laboratory studies.
Weak EvidenceEffective at: No established human dose
Supporting studies (click to view on PubMed):
A eucalyptus-containing topical blend matched prescription diclofenac for reducing musculoskeletal pain over one week.
Weak EvidenceEffective at: Twice-daily topical application for 7 days (multi-ingredient product)
Supporting studies (click to view on PubMed):
Absorption & Bioavailability
Unknown — no pharmacokinetic data in humans provided in the reviewed studies. Topical and inhaled routes are used clinically, but absorption and systemic levels are not characterized in the provided evidence.
Red Flags to Watch For
- Most human studies are small (11–72 participants) and short-term — long-term safety is not established
- Eucalyptus oil is toxic if swallowed in significant amounts — keep away from children and do not ingest undiluted oil
- Many supplement products combine eucalyptus with other ingredients, making it impossible to attribute effects to eucalyptus alone
- Anticancer claims circulating online are based entirely on lab and animal studies — no human clinical trial evidence exists in the provided data
- Retrospective rhinitis study lacked a control group, limiting confidence in the results
Products Containing Eucalyptus
See how Eucalyptus is used in these analyzed products:
Frequently Asked Questions
What does Eucalyptus do?
Plant-derived oil with early evidence for nasal relief, headache, and antimicrobial uses. Most research is preliminary.
What is the effective dose of Eucalyptus?
No established dose
Is Eucalyptus safe?
Most human studies are small (11–72 participants) and short-term — long-term safety is not established
What doesn't Eucalyptus do?
Not proven to treat or prevent cancer in humans — lab results don't translate to a cure.
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25